[The consequence of the preparation factors for the effect of the drug].
D000042:Absorption; D000284:Administration, Oral; D001702:Biopharmaceutics; D002214:Capsules; D002626:Chemistry, Pharmaceutical; D002701:Chloramphenicol; D004077:Digoxin; D006801:Humans; D009582:Nitrofurantoin; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D014677:Pharmaceutical Vehicles; D010672:Phenytoin; D013329:Structure-Activity Relationship; D013488:Suppositories; D013607:Tablets; D013608:Tablets, Enteric-Coated; D013752:Tetracycline; D013997:Time Factors; D014044:Tolbutamide
D002214:Capsules; D004364:Pharmaceutical Preparations; D014677:Pharmaceutical Vehicles; D013488:Suppositories; D013607:Tablets; D013608:Tablets, Enteric-Coated; D010672:Phenytoin; D002701:Chloramphenicol; D004077:Digoxin; D009582:Nitrofurantoin; D014044:Tolbutamide; D013752:Tetracycline
Formuleringsfaktorenes betydning for legemiddeleffekten.